전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
metrorāģija
metrorrhagia
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
metrorāģija impotence
metrorrhagia impotence
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
metrorāģija, menorāģija
metrorrhagia, menorrhagia
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
metrorāģija olnīcas cista
breast complaints1
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
retāk metrorāģija, menorāģija
metrorrhagia, menorrhagia
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
amenoreja, menorāģija, metrorāģija
amenorrhoea, menorrhagia, metrorrhagia
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
amenoreja ejakulācijas traucējumi menorāģija metrorāģija
amenorrhoea ejaculation disorder menorrhagia metrorrhagia
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
metrorāģija, menorāģija, sāpes krūšu dziedzeros, sāpes iegurnī
metrorrhagia, menorrhagia, breast pain, pelvic pain
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
dismenoreja, menorāģija, metrorāģija, dzemdes spazmas, vagināli izdalījumi
application site dermatitis, application site discolouration, application site hypersensitivity, application site pain, application site papules, application site vesicles, generalized oedema
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
impotence, amenoreja, ejakulācijas traucējumi, menorāģija, metrorāģija vispārēji traucējumi
impotence, amenorrhoea, abnormal ejaculation, menorrhagia, metrorrhagia general disorders
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
ar interferonu lietošanu tiek saistīta anoreksija, reibonis, trauksme, aritmijas, vazodilatācija un sirdsklauves, menorāģija, metrorāģija.
the administration of interferons has been associated with anorexia, dizziness, anxiety, arrhythmias, vasodilation and palpitation, menorrhagia and metrorrhagia.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
24- nedēļas ilgajos ar placebo kontrolētajos 3. fāzes pētījumos kombinētu menstruālā cikla traucējumu (amenoreja, dismenoreja, menorāģija, neregulāra menstruācija, metrorāģija, oligomenoreja un polimenoreja) sastopamība bija 9,9 % ar lumakaftoru/ivakaftoru ārstēto pacienšu un 1,7 % ar placebo ārstēto pacienšu.
during the 24-week, placebo-controlled, phase 3 studies, the incidence of combined menstrual abnormality events (amenorrhoea, dysmenorrhoea, menorrhagia, menstruation irregular, metrorrhagia, oligomenorrhoea, and polymenorrhoea) was 9.9 % in lumacaftor/ivacaftor-treated female patients and 1.7% in placebo-treated females.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질: